AGIO:NASDAQ
Agios Pharmaceuticals Inc
၃၃.၂၅ US$
arrow_downward
-၀.၁၅%(-၀.၀၅၀) 1D
၃၃.၂၅ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: စက် ၃၀, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AGIO...
Open
၃၃.၆၇ US$
High
၃၄.၀၆ US$
Low
၃၃.၂၀ US$
Mkt. cap
၁၉၈.၅၁ ဋေ
Avg. vol.
၉.၂၄ သိန်း
Volume
၁.၃၀ သန်း
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၇.၀၁ US$
Beta
၀.၆၀
Shares outstanding
၅.၉၇ ကုဋေ
No. of employees
၅၄၀
Open
၃၃.၆၇ US$
High
၃၄.၀၆ US$
Low
၃၃.၂၀ US$
Mkt. cap
၁၉၈.၅၁ ဋေ
Avg. vol.
၉.၂၄ သိန်း
Volume
၁.၃၀ သန်း
52-wk high
၄၅.၉၉ US$
52-wk low
၂၂.၂၄ US$
EPS
-၇.၀၁ US$
Beta
၀.၆၀
Shares outstanding
၅.၉၇ ကုဋေ
No. of employees
၅၄၀
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၁ ရက်
10 Health Care Stocks Whale Activity In Today’s Session
Profile
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
About Agios Pharmaceuticals Inc